About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 68827 record(s)
Req # A-2023-001173
Adverse Drug Reaction (ADR). Report number: E2B_02997619.Organization: Health Canada
February 2024
Req # A-2023-001204
Adverse Drug Reaction (ADR). Report number: E2B_06648474.Organization: Health Canada
February 2024
Req # A-2023-001234
Adverse Drug Reaction (ADR). Report number: E2B_06709011.Organization: Health Canada
February 2024
Req # A-2023-001268
Adverse Drug Reactions (ADRs). Report numbers: 001065721, 001065757, 001070834, 001073005.Organization: Health Canada
February 2024
Req # A-2023-001340
Adverse Drug Reactions (ADRs) for Atorvastatin-10. Report numbers: 000961592, 000989963, 001066344, 001068222. ADRs for Atorvastatin-20. Report numbers: 000732131, 000938663. ADRs for Atorvastatin-40. Report numbers: 000930000, E2B_02357512. ADR for…Organization: Health Canada
February 2024
Req # A-2023-001345
Adverse Drug Reaction (ADR). Report number: 001070471.Organization: Health Canada
February 2024
Req # A-2023-001360
Adverse Drug Reaction (ADR) for Midazolam. Report number: 001066753.Organization: Health Canada
February 2024
Req # A-2023-001363
Adverse Drug Reaction (ADR). Report number: 001051697.Organization: Health Canada
February 2024
Req # A-2015-000032
Documentation, forms, and paperwork relating to On-Site Evaluations done at Alexion Pharmaceuticals between December 3 - December 5 2008, Hoffman-La Roche between November 15 - November 20 2004, and Amgen Canada between February 12 - February 16…Organization: Health Canada
February 2024
Req # A-2018-001128
Any information pertaining to a recall, stop sale or any compliance and enforcement related activities involving Natural Product Number (NPN) 80037590 and NPN 80042116 licensed to Ferring Inc. from January 1, 2018 to November 13, 2018.Organization: Health Canada
February 2024